SARS-CoV-2 infection of human pluripotent stem cell-derived vascular cells reveals smooth muscle cells as key mediators of vascular pathology during infection
Abstract Although respiratory symptoms are the most prevalent disease manifestation of infection by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), nearly 20% of hospitalized patients are at risk for thromboembolic events. This prothrombotic state is considered a key factor in the incr...
Saved in:
| Main Authors: | Alexsia Richards, Andrew S. Khalil, Max Friesen, Troy W. Whitfield, Xinlei Gao, Tenzin Lungjangwa, Roger D. Kamm, Zhengpeng Wan, Lee Gehrke, David Mooney, Rudolf Jaenisch |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-12-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-024-54917-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vascular Smooth Muscle Cell Development and Cardiovascular Malformations
by: Lihua Qi, et al.
Published: (2021-12-01) -
Vascular Smooth Muscle Cells: A Therapeutic Target in Atherosclerosis
by: Lingna Zhao, et al.
Published: (2025-06-01) -
The role of MicroRNAs in mesenchymal stem cell differentiation into vascular smooth muscle cells
by: Sakhavat Abolhasani, et al.
Published: (2025-03-01) -
Mebendazole reduces vascular smooth muscle cell proliferation and neointimal formation following vascular injury in mice.
by: Jintao Wang, et al.
Published: (2014-01-01) -
Mechanical signaling regulates vascular smooth muscle cell adaptation in aging
by: Amin Mohajeri, et al.
Published: (2025-07-01)